β-hydroxybutyrate inhibits myocardial fatty acid oxidation in vivo independent of changes in malonyl-CoA content

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 285, Issue 4 54-4, 2003, Pages

  Stanley, William C ^a   Meadows, Steven R ^a   Kivilo, Krista M ^a   Roth, Bridgette A ^a   Lopaschuk, Gary D ^b  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Cardiac; Heart; Lactate; Metabolism

Indexed keywords

3 HYDROXYBUTYRIC ACID; ACETYL COENZYME A; ACETYL COENZYME A CARBOXYLASE; CARNITINE PALMITOYLTRANSFERASE; FATTY ACID; LIPID EMULSION; MALONYL COENZYME A; PALMITIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FATTY ACID BLOOD LEVEL; FATTY ACID OXIDATION; FATTY ACID TRANSPORT; HEART FUNCTION; HEART MUSCLE BIOPSY; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; SWINE;

EID: 0141788696     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00332.2003     Document Type: Article

References (37)

1. Avogaro A, Nosadini R, Doria A, Fioretto P, Velussi M, Vigorito C, Sacca L, Toffolo G, Cobelli C, and Trevisan R. Myocardial metabolism in insulin-deficient diabetic humans without coronary artery disease. Am J Physiol Endocrinol Metab 258: E606-E618, 1990.
2. Awan MM and Saggerson ED. Malonyl-CoA metabolism in cardiac myocytes and its relevance to the control of fatty acid oxidation. Biochem J 295: 61-66, 1993.
3. Chandler MP, Huang H, McElfresh TA, and Stanley WC. Increased nonoxidative glycolysis despite continued fatty acid uptake during demand-induced myocardial ischemia. Am J Physiol Heart Circ Physiol 282: H1871-H1878, 2002.
4. Chavez PN, Stanley WC, McElfresh TA, Huang H, Sterk JP, and Chandler MP. Effects of hyperglycemia and fatty acid oxidation inhibition during aerobic conditions and demand-induced ischemia. Am J Physiol Heart Circ Physiol 284: H1521-H1527, 2003.
5. Chen V, Wagner G, and Spitzer JJ. Regulation of substrate oxidation in isolated myocardial cells by beta-hydroxybutyrate. Horm Metab Res 16: 243-247, 1984.
6. Denton RM and Randle PJ. Concentrations of glycerides and phospholipids in rat heart and gastrocnemius muscles. Effects of alloxan-diabetes and perfusion. Biochem J 104: 416-422, 1967.
7. Dyck JR and Lopaschuk GD. Malonyl CoA control of fatty acid oxidation in the ischemic heart. J Mol Cell Cardiol 34: 1099-1109, 2002.
8. Forsey RG, Reid K, and Brosnan JT. Competition between fatty acids and carbohydrate or ketone bodies as metabolic fuels for the isolated perfused heart. Can J Physiol Pharmacol 65: 401-406, 1987.
9. Goodwin GW and Taegtmeyer H. Regulation of fatty acid oxidation of the heart by MCD and ACC during contractile stimulation. Am J Physiol Endocrinol Metab 277: E772-E777, 1999.
10. Hall JL, Lopaschuk GD, Barr A, Bringas J, Pizzurro RD, and Stanley WC. Increased cardiac fatty acid uptake with dobutamine infusion in swine is accompanied by a decrease in malonyl CoA levels. Cardiovasc Res 32: 879-885, 1996.
11. Hall JL, Stanley WC, Lopaschuk GD, Wisneski JA, Pizzurro RD, Hamilton CD, and McCormack JG. Impaired pyruvate oxidation but normal glucose uptake in diabetic pig heart during dobutamine-induced work. Am J Physiol Heart Circ Physiol 271: H2320-H2329, 1996.
12. Hamilton C and Saggerson ED. Malonyl-CoA metabolism in cardiac myocytes. Biochem J 350: 61-67, 2000.
13. Hasselbaink DM, Glatz JF, Luiken JJ, Roemen TH, and Van der Vusse GJ. Ketone bodies disturb fatty acid handling in isolated cardiomyocytes derived from control and diabetic rats. Biochem J 371: 753-760, 2003.
14. Kudo N, Barr AJ, Barr RL, Desai S, and Lopaschuk GD. High rates of fatty acid oxidation during reperfusion of ischemic hearts are associated with a decrease in malonyl-CoA levels due to an increase in 5′-AMP-activated protein kinase inhibition of acetyl-CoA carboxylase. J Biol Chem 270: 17513-17520, 1995.
15. Kunau WH, Dommes V, and Schulz H. Beta-oxidation of fatty acids in mitochondria, peroxisomes, and bacteria: a century of continued progress. Prog Lipid Res 34: 267-342, 1995.
16. Lammerant J, Huynh-Thu T, and Kolanowski J. Inhibitory effects of the D(-)isomer of 3-hydroxybutyrate on cardiac nonesterified fatty acid uptake and oxygen demand induced by norepinephrine in the intact dog. J Mol Cell Cardiol 17: 421-433, 1985.
17. Little JR, Goto M, and Spitzer JJ. Effect of ketones on metabolism of FFA by dog myocardium and skeletal muscle in vivo. Am J Physiol 219: 1458-1463, 1970.
18. Lommi J, Koskinen P, Naveri H, Harkonen M, and Kupari M. Heart failure ketosis. J Intern Med 242: 231-238, 1997.
19. Lommi J, Kupari M, Koskinen P, Naveri H, Leinonen H, Pulkki K, and Harkonen M. Blood ketone bodies in congestive heart failure. J Am Coll Cardiol 28: 665-672, 1996.
20. Lommi J, Kupari M, and Yki-Jarvinen H. Free fatty acid kinetics and oxidation in congestive heart failure. Am J Cardiol 81: 45-50, 1998.
21. Lopaschuk GD, Belke DD, Gamble J, Itoi T, and Schonekess BO. Regulation of fatty acid oxidation in the mammalian heart in health and disease. Biochim Biophys Acta 1213: 263-276, 1994.
22. Lysiak W, Toth PP, Suelter CH, and Bieber LL. Quantitation of the efflux of acylcarnitines from rat heart, brain, and liver mitochondria. J Biol Chem 261: 13698-13703, 1986.
23. Newsholme EA and Randle PJ. Regulation of glucose upake by muscle. Effects of fatty acids, ketone bodies and pyruvate, and of alloxan diabetes, starvation, hypophysectomy, and adrenalectomy, on the concentrations of hexose phosphates, nucleotides, and inorganic phosphate in perfused rat heart. Biochem J 93: 641-651, 1964.
24. Opie LH. The Heart: Physiology and Metabolism. New York: Raven, 1991.
25. Randle PJ. Fuel selection in animals. Biochem Soc Trans 14: 799-806, 1986.
26. Randle PJ, Newsholme EA, and Garland PB. Regulation of glucose uptake by muscle. 8. Effects of fatty acids, ketone bodies and pyruvate, and of alloxan-diabetes and starvation, on the uptake and metabolic fate of glucose in rat heart and diaphragm muscles. Biochem J 93: 652-665, 1964.
27. Recchia FA, Osorio JC, Chandler MP, Xu X, Panchal AR, Lopaschuk GD, Hintze TH, and Stanley WC. Reduced synthesis of NO causes marked alterations in myocardial substrate metabolism in conscious dogs. Am J Physiol Endocrinol Metab 282: E197-E206, 2002.
28. Riley M, Elborn JS, McKane WR, Bell N, Stanford CF, and Nicholls DP. Resting energy expenditure in chronic cardiac failure. Clin Sci (Lond) 80: 633-639, 1991.
29. Saddik M, Gamble J, Witters LA, and Lopaschuk GD. Acetyl-CoA carboxylase regulation of fatty acid oxidation in the heart. J Biol Chem 268: 25836-25845, 1993.
30. Saha AK, Vavvas D, Kurowski TG, Apazidis A, Witters LA, Shafrir E, and Ruderman NB. Malonyl-CoA regulation in skeletal muscle: its link to cell citrate and the glucose-fatty acid cycle. Am J Physiol Endocrinol Metab 272: E641-E648, 1997.
31. Stanley WC, Hall JL, Hacker TA, Hernandez LA, and Whitesell LF. Decreased myocardial glucose uptake during ischemia in diabetic swine. Metabolism 46: 168-172, 1997.
32. Stanley WC, Hernandez LA, Spires D, Bringas J, Wallace S, and McCormack JG. Pyruvate dehydrogenase activity and malonyl CoA levels in normal and ischemic swine myocardium: effects of dichloroacetate. J Mol Cell Cardiol 28: 905-914, 1996.
33. Stanley WC, Lopaschuk GD, Hall JL, and McCormack JG. Regulation of myocardial carbohydrate metabolism under normal and ischaemic conditions. Potential for pharmacological interventions. Cardiovasc Res 33: 243-257, 1997.
34. Sultan AM. Effects of diabetes and insulin on ketone bodies metabolism in heart. Mol Cell Biochem 110: 17-23, 1992.
35. Taegtmeyer H. Energy metabolism of the heart: from basic concepts to clinical applications. Curr Probl Cardiol 19: 59-113, 1994.
36. Vanoverschelde JL, Wijns W, Kolanowski J, Bol A, Decoster PM, Michel C, Cogneau M, Heyndrickx GR, Essamri B, and Melin JA. Competition between palmitate and ketone bodies as fuels for the heart: study with positron emission tomography. Am J Physiol Heart Circ Physiol 264: H701-H707, 1993.
37. 14C-labeled substrates in humans. J Clin Invest 79: 359-366, 1987.